0000911916-17-000020.txt : 20170104
0000911916-17-000020.hdr.sgml : 20170104
20170104161922
ACCESSION NUMBER: 0000911916-17-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170103
FILED AS OF DATE: 20170104
DATE AS OF CHANGE: 20170104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001348649
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203419541
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 781-365-2596
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc
DATE OF NAME CHANGE: 20060104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lawton Alison Frances
CENTRAL INDEX KEY: 0001542650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37358
FILM NUMBER: 17505675
MAIL ADDRESS:
STREET 1: 39 ROBINSON ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02420
FORMER NAME:
FORMER CONFORMED NAME: LAWTON ALISON FRANCIS
DATE OF NAME CHANGE: 20120216
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-01-03
0001348649
CoLucid Pharmaceuticals, Inc.
CLCD
0001542650
Lawton Alison Frances
C/O COLUCID PHARMACEUTICALS, INC.
222 THIRD STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
36.20
2017-01-03
4
A
0
658
30.40
A
2017-01-03
2027-01-03
Common Stock
658
658
D
This option was issued to the reporting person pursuant to the CoLucid Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash compensation of $20,000.
/s/ Christine G. Long, Attorney-in-Fact for Alison Lawton (power of attorney previously filed)
2017-01-04